When Using Artificial Intelligence In Pharma R&D, Start With Identifying Problem To Solve

 
• By Malcolm Spicer

VeriSIM uses generative AI for questions such as changing a drug molecule’s chemistry and machine learning to better predict potential biological implications, says CEO Jo Varshney.

VeriSIM Life's BioSIM “virtual drug development engine” narrows the number of drug compounds that offer anticipated value for the treatment or cure of specific illness or disease. • Source: VeriSIM Life

More from AI

More from Advanced Technologies